Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 10, 2003, Pages 1348-1354

  Jindani, Amina ^b   Doré, Caroline J ^b   Mitchison, Denis A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

Bactericidal; Early bactericidal activity; Extended early bactericidal activity; Pulmonary tuberculosis; Sterilizing

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; CONFIDENCE INTERVALS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PROBABILITY; PYRAZINAMIDE; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; STREPTOMYCIN; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0038628994     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200210-1125OC     Document Type: Article

References (28)

1. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980;121:939-949.
2. Mitchison DA, Sturm WA. The measurement of early bactericidal activity. In: Malin A, McAdam KPWJ, editors. Baillière's clinical infectious diseases: Mycobacterial diseases. Part II. London: Baillière Tindall; 1997. p. 185-206.
3. Donald PR, Sirgel FA, Venter A, Smit E, Parkin DP, van de Wal BW, Doré CJ, Mitchison DA. The early bactericidal activity of streptomycin. Int J Tuberc Lung Dis 2002:6:693-698.
4. Donald PR, Sirgel FA, Kanyok TP, Danziger LH, Venter A, Botha FJ, Parkin DP, Seifart HI, van de Wal BW, Maritz JS, et al. The early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis. Antimicrob Agents Chemother 2000;44:3285-3287.
5. Donald PR, Sirgel FA, Venter A, Smith E, Parkin DP, van de Wal BW, Mitchison DA. The early bactericidal activity of amikacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2001;5:533-538.
6. Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van de Wal BW, Maritz JS, Mitchison DA. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997;156:895-900.
7. Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, Tam CM, Lam KM, Lam CW, Sole KM, Mitchison DA, EBA Collaborative Study Group. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother 2000;45:859-870.
8. Brindle R, Odhiambo J, Mitchison D. Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis. BMC Pulm Med 2001;1:2.
9. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
10. Sirgel F, Venter A, Mitchison D. Sources of variation in studies of the early bactericidal activity of antituberculosis drugs. J Antimicrob Chemother 2001;47:177-182.
11. Botha FJH, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S Afr Med J 1996;86:155-158.
12. Dickinson JM, Mitchison DA. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis 1981;123:367-371.
13. Snedecor GW, Cochran WG. Statistical methods, 8th ed. Ames, IA: Iowa State University Press; 1989. p. 400-404.
14. Gillespie SH, Gosling RD, Charalambous BM. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. Am J Respir Crit Care Med 2002;166:31-35.
15. Mitchison DA, Gillespie SH, Charalambous BM, Gosling RD. A reiterative method for calculating bactericidal activity. Am J Respir Crit Care Med 2003;163:663-664.
16. Doré CJ, Nunn AJ, Gillespie SH, Gosling RD, Charalambous BM. Bactericidal activity of antituberculosis drugs. Am J Respir Crit Care Med 2003;167:663.
17. Global Alliance for Tuberculosis Drug Development. Tuberculosis: scientific blueprint for TB drug development. Tuberculosis 2001;81:1-52.
18. East African/British Medical Research Council. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1973;1:1331-1339.
19. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, 3x weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide. Am Rev Respir Dis 1991;143:700-706.
20. Mitchison DA. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. J Appl Bacteriol Symp Suppl 1996;81(Suppl.):72S-80S.
21. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1984, with relevant subsequent publications. Int J Tuberc Lung Dis 1999;3:S231-S279.
22. Dickinson JM, Aber VR, Mitchison DA. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis. Am Rev Respir Dis 1977;116:627-635.
23. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 4 three-times weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Tubercle 1982;63:89-98.
24. British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Br J Dis Chest 1981;75:141-153.
25. East African/British Medical Research Council. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: second report. Tubercle 1980: 61:59-69.
26. East and Central African/British Medical Research Councils. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis (fifth collaborative study): final report. Tubercle 1986;67:5-15.
27. East African/British Medical Research Councils. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis: second report of the 4th sludy. Am Rev Respir Dis 1981;123:165-170.
28. Zhang Y, Mitchison DA. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003;7:6-21.